TY - JOUR
T1 - Psychometric Validation of the Patient Anal Cancer Knowledge Scale (PACKS) in a Cohort of Black and Hispanic/Latino Sexual and Gender Diverse Young Adults
AU - Wheldon, Christopher W.
N1 - Publisher Copyright:
© 2023, The Author(s) under exclusive licence to American Association for Cancer Education.
PY - 2023/12
Y1 - 2023/12
N2 - Lack of anal cancer information in priority populations is a major barrier to the uptake and utilization of prevention services. A validated measure of anal cancer knowledge is needed to inform patient education and shared clinical decision-making for anal cancer prevention. The purpose of this study was to validate the Patient Anal Cancer Knowledge Scale (PACKS) in a sample of GBM, namely Black and Hispanic gay, bisexual, and other men who have sex with men (GBM) and gender expansive young adults (aged 18–30 years) living in the USA (N=188). Anal cancer knowledge was hypothesized as a 3-factor scale representing (1) risk and primary prevention (9 items), (2) symptoms (5 items), and (3) screening (3 items). Confirmatory factor analysis, internal consistency, and criterion validity were assessed. The 3-factor model demonstrated adequate fit (RMSEA=0.02; CFI=0.99). All items loaded on their respective factors (p<0.01). Scale scores indicated low to moderate anal cancer knowledge and acceptable reliability: factor 1 (M=3.5; SD=2.3; range: 0–9; α=.71), factor 2 (M=2.9; SD=1.9; range: 0–5; α=.85), and factor 3 (M=2.0; SD=1.2; range: 0–3; α=.79). History of HPV vaccination (51.3%) was positively correlated with factors 1 and 2. The PACKS demonstrated good construct validity related to knowledge of anal cancer risk, prevention, symptoms, and screening. Limited anal cancer knowledge among Black and Hispanic GBM is a potential barrier to the uptake and utilization of prevention recommendations.
AB - Lack of anal cancer information in priority populations is a major barrier to the uptake and utilization of prevention services. A validated measure of anal cancer knowledge is needed to inform patient education and shared clinical decision-making for anal cancer prevention. The purpose of this study was to validate the Patient Anal Cancer Knowledge Scale (PACKS) in a sample of GBM, namely Black and Hispanic gay, bisexual, and other men who have sex with men (GBM) and gender expansive young adults (aged 18–30 years) living in the USA (N=188). Anal cancer knowledge was hypothesized as a 3-factor scale representing (1) risk and primary prevention (9 items), (2) symptoms (5 items), and (3) screening (3 items). Confirmatory factor analysis, internal consistency, and criterion validity were assessed. The 3-factor model demonstrated adequate fit (RMSEA=0.02; CFI=0.99). All items loaded on their respective factors (p<0.01). Scale scores indicated low to moderate anal cancer knowledge and acceptable reliability: factor 1 (M=3.5; SD=2.3; range: 0–9; α=.71), factor 2 (M=2.9; SD=1.9; range: 0–5; α=.85), and factor 3 (M=2.0; SD=1.2; range: 0–3; α=.79). History of HPV vaccination (51.3%) was positively correlated with factors 1 and 2. The PACKS demonstrated good construct validity related to knowledge of anal cancer risk, prevention, symptoms, and screening. Limited anal cancer knowledge among Black and Hispanic GBM is a potential barrier to the uptake and utilization of prevention recommendations.
KW - Adolescent
KW - Adult
KW - Anus Neoplasms/diagnosis
KW - Black or African American
KW - Hispanic or Latino
KW - Homosexuality, Male
KW - Humans
KW - Male
KW - Psychometrics
KW - Reproducibility of Results
KW - Sexual and Gender Minorities
KW - Young Adult
KW - Anal neoplasms/prevention and control
KW - Measurement
KW - Oncology
KW - Minority groups
KW - Preventive health services
KW - Patient education
UR - http://www.scopus.com/inward/record.url?scp=85169157682&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:001064613500001&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1007/s13187-023-02362-0
DO - 10.1007/s13187-023-02362-0
M3 - Article
C2 - 37648950
SN - 0885-8195
VL - 38
SP - 1925
EP - 1931
JO - Journal of Cancer Education
JF - Journal of Cancer Education
IS - 6
ER -